Interesting to know. Thanks!

-D

> On Oct 27, 2022, at 11:06 PM, Karl Wittnebel via Mercedes 
> <mercedes@okiebenz.com> wrote:
> 
> In case anyone cares: The latest on ivermectin for covid; basically no
> better than placebo in time to recovery for over 30yo outside the hospital.
> This is a randomized controlled trial, which is pretty much the strongest
> type of design for proof in a clinical trial:
> 
> https://jamanetwork.com/journals/jama/fullarticle/2797483
> 
> On Thu, Oct 27, 2022, 5:35 PM dan penoff.com via Mercedes <
> mercedes@okiebenz.com> wrote:
> 
>> I love the color!
>> 
>> https://www.facebook.com/marketplace/item/5367679576681612/
>> 
>> -D
>> _______________________________________
>> http://www.okiebenz.com
>> 
>> To search list archives http://www.okiebenz.com/archive/
>> 
>> To Unsubscribe or change delivery options go to:
>> http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com
>> 
>> 
> _______________________________________
> http://www.okiebenz.com
> 
> To search list archives http://www.okiebenz.com/archive/
> 
> To Unsubscribe or change delivery options go to:
> http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com
> 


_______________________________________
http://www.okiebenz.com

To search list archives http://www.okiebenz.com/archive/

To Unsubscribe or change delivery options go to:
http://mail.okiebenz.com/mailman/listinfo/mercedes_okiebenz.com

Reply via email to